Understanding the regulation of mutant EGF receptors commonly found in lung cancers could lead to new targeted therapies.

Patients treated in intensive care units across the globe enter their medical care with no evidence of cognitive impairment but often leave with deficits similar to those seen in patients with traumatic brain injury (TBI) or mild Alzheimer’s disease (AD) that persist for at least a year, according to a Vanderbilt University Medical Center study published today in the New England Journal of Medicine.

While the Framingham Heart Study is often referenced throughout the halls of academia, few know its origin or can fully appreciate the contribution it has made to the understanding and prevention of cardiovascular disease.

Vanderbilt investigators used an in vivo screen in zebrafish to identify a potential new anti-cancer drug.

VUMC researchers have reported promising results in using oral antimycobacterial therapy to treat chronic cutaneous sarcoidosis, considered by clinicians a difficult illness to effectively control.

"Vanderbilt's Nobel Prize," the Earl Sutherland Prize for achievement in research, was awarded to John Gore at the Fall Faculty Assembly, while Gordon Bernard received the Thomas Jefferson Award for distinguished service to Vanderbilt.

Robert Coffey Jr., M.D., Ingram Professor of Cancer Research at Vanderbilt University, has received a five-year, $5.2 million grant from the National Institutes of Health (NIH) to study the role of extracellular RNA (ex-RNA) in colorectal cancer.